Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2021-09-23 | 2021-10-28 | 146125 |
| FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2023-04-27 | 2023-06-21 | 190698 |
| FENTORA | 600MCG | TABLET (EFFERVESCENT) | Resolved | 2023-06-08 | 2023-10-04 | 194172 |
| FENTORA | 600MCG | TABLET (EFFERVESCENT) | Resolved | 2023-06-19 | 2023-07-05 | 195548 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Actual shortage | 2024-05-03 | 2024-05-03 | 226942 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2024-05-09 | 2024-05-16 | 227506 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2017-08-01 | 2018-05-11 | 17844 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2019-09-26 | 2019-10-04 | 94825 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Avoided shortage | 2019-11-21 | 2020-07-10 | 99453 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2020-03-26 | 2020-05-08 | 109583 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2020-09-24 | 2020-10-22 | 124986 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-01-28 | 2021-04-08 | 132672 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-05-06 | 2021-06-10 | 138904 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-24 | 2021-07-15 | 141463 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-08-27 | 2021-09-23 | 144726 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-09-16 | 2022-04-21 | 145780 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2021-10-14 | 2022-02-17 | 147219 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-12-02 | 2022-02-10 | 150403 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Resolved | 2021-12-17 | 2022-02-05 | 151453 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2022-06-09 | 2022-06-17 | 162283 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |